Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-18, Stock:JNJ, The news for the past five days is as follows:
2019-07-11: NEWS1: These ETFs make investing easy — even if you’re broke.NEWS2: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS3: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS4: Avicanna Gets Conditional Approval To List On Toronto Stock Exchange Senior Board As R&D Issuer.NEWS5: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS6: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS7: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS8: Health Care Sector Update for 07/11/2019: SNSS, EYEN, BHVN, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 07/11/2019: SNSS, EYEN, BHVN, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2019.NEWS11: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2019.NEWS12: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2019.NEWS13: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2019.NEWS14: UPDATE 1-Eli Lilly's bio-medicines head to leave next month.NEWS15: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS16: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS17: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.
2019-07-12: NEWS1: Here's Why Johnson & Johnson Dropped 4% Today.NEWS2: Here's Why Johnson & Johnson Dropped 4% Today.NEWS3: Dow, S&P, Nasdaq Close the Week at New Highs.NEWS4: Dow, S&P, Nasdaq Close the Week at New Highs.NEWS5: Here&apos;s Why Johnson & Johnson Dropped 4% Today.NEWS6: Johnson & Johnson Breaks Below 200-Day Moving Average - Notable for JNJ.NEWS7: Johnson & Johnson Breaks Below 200-Day Moving Average - Notable for JNJ.NEWS8: Market Close Report: Historical high reached as NASDAQ Composite Index closes at 8,244.15..NEWS9: Market Close Report: Historical high reached as NASDAQ Composite Index closes at 8,244.15..NEWS10: Dow Jones Today: A Fantastic Friday.NEWS11: J&J Stock Dives As Feds Reportedly Seek Criminal Probe Into Talc Powders.NEWS12: US STOCKS-Wall St notches all-time highs on lingering rate-cut optimism.NEWS13: 4 Top Stock Trades for Monday:JNJ, SQ, ILMN, ACB.NEWS14: J&J Denials of Asbestos in Baby Powder Spur Criminal Probe.NEWS15: Friday Sector Laggards: Healthcare, Utilities.NEWS16: Friday Sector Laggards: Healthcare, Utilities.NEWS17: 4 Healthcare Stocks That Are Feeling Sick.NEWS18: Johnson & Johnson tumbles amid reports of criminal investigation.NEWS19: J&J Draws U.S. DOJ Probe on Talcum Powder Asbestos Denials.NEWS20: Johnson & Johnson Baby Powder News: JNJ Stock Drops on Investigation.NEWS21: Notable Friday Option Activity: JNJ, NLSN, CAT.NEWS22: Notable Friday Option Activity: JNJ, NLSN, CAT.NEWS23: Johnson & Johnson Falls On Report Of Justice Department Probe.NEWS24: US STOCKS-Wall Street hits new highs on rate-cut optimism.NEWS25: J&J faces U.S. criminal probe related to baby powder - Bloomberg.NEWS26: J&J Stock Dives As Feds Reportedly Seek Criminal Probe Into Talc Powders.NEWS27: Johnson & Johnson stock dives 4.3% after Bloomberg reports that DOJ is pursuing criminal investigation into company.NEWS28: Johnson & Johnson Stock Drops on Baby Powder Report.NEWS29: J&J Stock Dives As DOJ Reportedly Seeks Criminal Probe Into Talc Powders.NEWS30: J&J faces U.S. criminal probe related to baby powder - Bloomberg.NEWS31: Johnson & Johnson faces criminal probe related to baby powder: Bloomberg.NEWS32: Why Earnings Season Could Be Great for Johnson & Johnson (JNJ).NEWS33: Why Earnings Season Could Be Great for Johnson & Johnson (JNJ).NEWS34: Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY.NEWS35: Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY.NEWS36: Johnson & Johnson to test experimental HIV vaccine in U.S., Europe.NEWS37: Why Earnings Season Could Be Great for Johnson & Johnson (JNJ).NEWS38: Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug.NEWS39: Health Care Sector Update for 07/12/2019: MDGS, HOOK, ILMN, JNJ, PFE, ABT, MRK, AMGN.NEWS40: Health Care Sector Update for 07/12/2019: MDGS, HOOK, ILMN, JNJ, PFE, ABT, MRK, AMGN.NEWS41: Bull of the Day: Penumbra (PEN).NEWS42: Bull of the Day: Penumbra (PEN).NEWS43: J&J Stock Sinks as Feds Probe Baby Powder Cancer Allegations.NEWS44: Dow 30 Stock Roundup: Cisco to Buy Acacia, Microsoft & ServiceNow Partnernership.NEWS45: Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY.NEWS46: Congo rules out using additional trial vaccines to combat Ebola.NEWS47: Here’s how many points a U.S.-China trade deal is worth to the S&P 500, according to J.P. Morgan’s top strategist.NEWS48: Bull of the Day: Penumbra (PEN).NEWS49: Drugmakers braced for opioid crisis reckoning.
2019-07-15: NEWS1: Stocks End Choppy Session at New Highs.NEWS2: Stocks End Choppy Session at New Highs.NEWS3: J&J Submits BLA for Subcutaneous Formulation of Darzalex.NEWS4: AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes.NEWS5: Pre-Market Earnings Report for July 16, 2019 :  JPM, JNJ, WFC, GS, PLD, CP, FRC, DPZ, CBSH, SNV, FHN, MBWM.NEWS6: Pre-Market Earnings Report for July 16, 2019 :  JPM, JNJ, WFC, GS, PLD, CP, FRC, DPZ, CBSH, SNV, FHN, MBWM.NEWS7: Daily Dividend Report: JNJ, VMC, AGCO, GT, CBT.NEWS8: Daily Dividend Report: JNJ, VMC, AGCO, GT, CBT.NEWS9: Citigroup, Johnson & Johnson, IBM, and More Stocks to Watch This Week.NEWS10: Johnson & Johnson Q2 Earnings Outlook.NEWS11: These Stocks Are Unlike The Others; Can You Profit From Them?.NEWS12: Tracking XLV ETF And SPDR ETFs: These Stocks Are Unlike The Others; Can You Profit From Them?.NEWS13: Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results.NEWS14: Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results.NEWS15: Monday’s Vital Data: Johnson & Johnson, Ford and Square.NEWS16: Monday’s Vital Data: Johnson & Johnson, Ford and Square.NEWS17: UPDATE 4-Opioid 'kingpin' J&J fueled epidemic, Oklahoma argues at trial's end.NEWS18: Why Johnson & Johnson (JNJ) Might Surprise This Earnings Season.NEWS19: Why Johnson & Johnson (JNJ) Might Surprise This Earnings Season.NEWS20: Dow ETF Appears Strong Ahead of Q2 Earnings.NEWS21: Dow ETF Appears Strong Ahead of Q2 Earnings.NEWS22: Bull Signal Sounds for Johnson & Johnson Stock Before Earnings.NEWS23: Company News for Jul 15, 2019.NEWS24: Company News for Jul 15, 2019.NEWS25: Dow Movers: GS, MRK.NEWS26: Dow Movers: GS, MRK.NEWS27: Johnson & Johnson (JNJ) 2nd Quarter Earnings: What to Expect.NEWS28: Johnson & Johnson (JNJ) 2nd Quarter Earnings: What to Expect.NEWS29: Dow ETF Appears Strong Ahead of Q2 Earnings.NEWS30: J&J Falls Amid Reports of Criminal Probe Into Talcum Powder.NEWS31: J&J Falls Amid Reports of Criminal Probe Into Talcum Powder.NEWS32: CORRECTED-UPDATE 2-Oklahoma at trial's end says opioid 'kingpin' J&J fueled epidemic.NEWS33: Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2019.NEWS34: Why Johnson & Johnson (JNJ) Might Surprise This Earnings Season.NEWS35: Earnings Season Starts With Beat From Citigroup; Other Banks, Netflix Report Later In Week.NEWS36: Here’s What’s Overshadowing JNJ’s HIV Vaccine Progress.NEWS37: Company News for Jul 15, 2019.NEWS38: Monday’s Vital Data: Johnson & Johnson, Ford and Square.NEWS39: Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results.NEWS40: J&J Falls Amid Reports of Criminal Probe Into Talcum Powder.NEWS41: J&J Reports Earnings Under a Cloud of Baby Powder.NEWS42: Earnings Watch: Expect drama in second-quarter numbers as trade fears weigh.NEWS43: J&J earnings preview: Wall Street is still optimistic despite company’s legal issues.NEWS44: Opioid 'kingpin' J&J fuelled epidemic, Oklahoma argues at trial's end.NEWS45: Opioid 'kingpin' J&J fueled epidemic, Oklahoma argues at trial's end.NEWS46: Johnson & Johnson Is Reporting Its Earnings on Tuesday. Here’s What To Expect..
2019-07-16: NEWS1: Johnson & Johnson Earnings: JNJ Stock Dips Despite Q2 Beat, Raised Guidance.NEWS2: Johnson & Johnson Earnings: JNJ Stock Dips Despite Q2 Beat, Raised Guidance.NEWS3: Johnson & Johnson (JNJ) Q2 2019 Earnings Call Transcript.NEWS4: Johnson & Johnson (JNJ) Q2 2019 Earnings Call Transcript.NEWS5: Johnson & Johnson Registers 2nd-Quarter Earnings Beat.NEWS6: Here's Why J&J Stock Is Sliding Despite A Second-Quarter Beat.NEWS7: US STOCKS-Wall Street slips as bank earnings, Trump trade comments weigh.NEWS8: Stocks close down after Trump says ‘a long way to go’ on trade and investors digest bank earnings.NEWS9: Health Care Sector Update for 07/16/2019: ONCS,CGIX,IDXG,GNMX,JNJ.NEWS10: Health Care Sector Update for 07/16/2019: ONCS,CGIX,IDXG,GNMX,JNJ.NEWS11: Johnson & Johnson CFO on the opioid crisis: 'We don’t believe we were the cause'.NEWS12: Dow Jones Today: Earnings Disappointments.NEWS13: Stocks slip slightly amid trade remarks, earnings season.NEWS14: US STOCKS-S&P 500 edges lower after mixed bank earnings, Trump comments.NEWS15: Johnson & Johnson (JNJ) Q2 2019 Earnings Call Transcript.NEWS16: J&J Ups Sales Forecast as Cancer Drugs Drive Growth.NEWS17: Health Care Sector Update for 07/16/2019: CGIX,IDXG,GNMX,JNJ.NEWS18: Health Care Sector Update for 07/16/2019: CGIX,IDXG,GNMX,JNJ.NEWS19: Stocks slip after Trump says ‘a long way to go’ on trade and investors digest bank earnings.NEWS20: What Q2 Johnson & Johnson earnings display about the company's future.NEWS21: Here's Why J&J Stock Is Sliding Despite A Second-Quarter Beat.NEWS22: J&J stock falls despite earnings beat and guidance boost.NEWS23: US Stocks Little Moved as Earnings Roll In Tuesday.NEWS24: US STOCKS-Wall Street edges lower after mixed bank earnings, Trump comments.NEWS25: Johnson & Johnson Earnings: JNJ Stock Dips Despite Q2 Beat, Raised Guidance.NEWS26: Better-Than Expected Retail Sales in June.NEWS27: Better-Than Expected Retail Sales in June.NEWS28: AbbVie (ABBV) Acquires Mavupharma to Boost Cancer Portfolio.NEWS29: AbbVie (ABBV) Acquires Mavupharma to Boost Cancer Portfolio.NEWS30: Dow Analyst Moves: JNJ.NEWS31: Dow Analyst Moves: JNJ.NEWS32: Johnson & Johnson Jumps on Earnings Beat.NEWS33: Stocks slip to near session lows after Trump says ‘a long way to go’ on trade.NEWS34: J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View.NEWS35: J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View.NEWS36: Retail Sales Up, Import Prices Down, Q2 Earnings Solid.NEWS37: Retail Sales Up, Import Prices Down, Q2 Earnings Solid.NEWS38: Stocks waver, Dow hits new intraday high as investors parse trio of bank earnings.NEWS39: UPDATE 2-Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook.NEWS40: AbbVie (ABBV) Acquires Mavupharma to Boost Cancer Portfolio.NEWS41: US STOCKS-Wall Street muted after mixed bank earnings.NEWS42: Better-Than Expected Retail Sales in June.NEWS43: J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View.NEWS44: Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates.NEWS45: Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates.NEWS46: Dow Jones Leads Stock Market Action, As Three Blue Chip Stocks Report Earnings.NEWS47: Retail Sales Up, Import Prices Down, Q2 Earnings Solid.NEWS48: Mostly Strong Results For Big Banks, And J&J Another Solid Earnings Performer.NEWS49: Goldman's stock rally helps keep Dow positive.NEWS50: Goldman&apos;s stock rally helps keep Dow positive.NEWS51: Dow hits new intraday high as investors parse trio of bank earnings.NEWS52: Health Care Sector Update for 07/16/2019: IMRN, MLNT, JNJ, PFE, ABT, MRK, AMGN.NEWS53: Health Care Sector Update for 07/16/2019: IMRN, MLNT, JNJ, PFE, ABT, MRK, AMGN.NEWS54: US STOCKS-Futures flat after JPMorgan results; Goldman Sachs, Wells Fargo eyed.NEWS55: US STOCKS-Wall Street set for subdued open after mixed bank reports.NEWS56: Stocks Open Lower As Dow Jones Stocks Goldman, J&J and JPMorgan Report.NEWS57: Stocks pull back from record levels as earnings season picks up steam.NEWS58: 3 Dow Leaders with Double-Digit Upside.NEWS59: 3 Dow Leaders with Double-Digit Upside.NEWS60: Stocks - JP Morgan, Wells Fargo Fall Premarket; J&J, Goldman Sachs Rise.NEWS61: Johnson & Johnson’s Earnings Beat Estimates, but the Stock Isn’t Taking Off.NEWS62: Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates.NEWS63: Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook.NEWS64: J&J beats Wall Street expectations for second-quarter earnings, boosts guidance.NEWS65: Stock Futures Climb As Dow Jones Stocks Goldman, J&J and JPMorgan Report.NEWS66: The 2 Safest Dividend Stocks on the Planet.NEWS67: The 2 Safest Dividend Stocks on the Planet.NEWS68: Dow Jones Futures: Facebook Libra Unites Washington; Dow Stocks JPMorgan, Goldman Sachs, J&J Report.NEWS69: U.S. stocks set to tread water as investors parse trio of bank earnings.NEWS70: Shares of J&J up 0.8% after earnings and revenue beat.NEWS71: Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook.NEWS72: Dow Jones Stock J&J Earnings, Sales Top Views.NEWS73: Johnson & Johnson Reports 2019 Second-Quarter Results.NEWS74: Johnson & Johnson to Host Earnings Call.NEWS75: The 2 Safest Dividend Stocks on the Planet.NEWS76: [video]Johnson & Johnson Tops Q2 Earnings Estimate, Boosts 2019 Sales Forecast.NEWS77: Johnson & Johnson Lifts Sales Guidance After Q2 Earnings Beat.NEWS78: AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes.NEWS79: AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes.NEWS80: J&J Submits BLA for Subcutaneous Formulation of Darzalex.NEWS81: J&J Submits BLA for Subcutaneous Formulation of Darzalex.
2019-07-17: NEWS1: These 4 Medical Stocks Could Benefit From J&J Earnings — Here's Why.NEWS2: FlexShares Makes A Big Low Vol ETF Splash.NEWS3: After Earnings Beat, Wall Street Talks Johnson & Johnson Litigation Risk.NEWS4: Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat.NEWS5: Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat.NEWS6: XLRE, SHE: Big ETF Inflows.NEWS7: XLRE, SHE: Big ETF Inflows.NEWS8: Company News for Jul 17, 2019.NEWS9: Company News for Jul 17, 2019.NEWS10: Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat.NEWS11: Health Care Sector Update for 07/17/2019: GHSI, IMRN, ABT, JNJ, PFE, MRK, AMGN.NEWS12: Health Care Sector Update for 07/17/2019: GHSI, IMRN, ABT, JNJ, PFE, MRK, AMGN.NEWS13: Company News for Jul 17, 2019.NEWS14: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for July 18, 2019.NEWS15: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for July 18, 2019.NEWS16: WHO declares emergency over Ebola epidemic in Congo.NEWS17: Opioid makers dumped 76 billion pills onto U.S. market over 7 critical years, data shows.NEWS18: Dow Jones Today: Earnings Disappointments.NEWS19: Dow Jones Today: Earnings Disappointments.

Answer: Rise